Evidence map›Paper›PMID 32671067›Full record

ArticleFrontiers in cell and developmental biology2020

MicroRNA-223 Regulates Retinal Function and Inflammation in the Healthy and Degenerating Retina.

Nilisha Fernando, Josephine H C Wong, Shannon Das, Catherine Dietrich, Riemke Aggio-Bruce, Adrian V Cioanca, Yvette Wooff, Joshua A Chu-Tan, Ulrike Schumann, Chinh Ngo and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Serum miRNA modulations indicate changes in retinal morphology.Frontiers in molecular neuroscience · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. The Impact of miRNAs in Health and Disease of Retinal Pigment Epithelium.Frontiers in cell and developmental biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Nilisha FernandoThe John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Josephine H C WongThe John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Shannon DasThe John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Catherine DietrichThe John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Riemke Aggio-BruceThe John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Adrian V CioancaThe John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Yvette WooffThe John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Joshua A Chu-TanThe John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Ulrike SchumannThe John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Chinh NgoThe John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Rohan W EssexAcademic Unit of Ophthalmology, The Australian National University, Canberra, ACT, Australia.
Camilla DorianRobinson Research Institute, School of Medicine, The University of Adelaide, Adelaide, SA, Australia.
Sarah A RobertsonRobinson Research Institute, School of Medicine, The University of Adelaide, Adelaide, SA, Australia.
Si Ming ManThe John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Jan ProvisThe John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Riccardo NatoliThe John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Australian National University · AUUniversity of Adelaide · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMicroRNAs (miRNAs) are small, non-coding RNA molecules that have powerful regulatory properties, with the ability to regulate multiple messenger RNAs (mRNAs) and biological pathways. MicroRNA-223-3p (miR-223) is known to be a critical regulator of the innate immune response, and its dysregulation is thought to play a role in inflammatory disease progression. Despite miR-223 upregulation in numerous neurodegenerative conditions, largely in cells of the myeloid lineage, the role of miR-223 in the retina is relatively unexplored. Here, we investigated miR-223 in the healthy retina and in response to retinal degeneration.

methodsmiR-223-null mice were investigated in control and photo-oxidative damage-induced degeneration conditions. Encapsulated miR-223 mimics were intravitreally and intravenously injected into C57BL/6J wild-type mice. Retinal functional responses were measured using electroretinography (ERG), while extracted retinas were investigated by retinal histology (TUNEL and immunohistochemistry) and molecular analysis (qPCR and FACS).

resultsRetinal function in miR-223

conclusionmiR-223 is required for maintaining normal retinal function, as well as regulating inflammation in microglia and macrophages. Further investigations are required to determine the targets of miR-223 and their key biological pathways and interactions that are relevant to retinal diseases. Future studies should investigate whether sustained delivery of miR-223 into the retina is sufficient to target these pathways and protect the retina from progressive degeneration.

Indexed as

macrophagemicrogliamicroRNAmicroRNA-223neuroinflammationphotoreceptor cell deathretinal degenerationretinal function

Identifiers

PMID32671067
PMCPMC7333019
OpenAlexW3037036500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.